As manufacturers continue to invest in facilities throughout Ireland, J&J is looking to get in on the action even more.
The company announced on Friday that its vision subsidiary, Johnson & Johnson Vision Care Ireland, will expand its manufacturing facility in Plassey, Ireland, a suburb of the city of Limerick.
The company is placing a €100 million ($100.2 million) investment in the facility, which includes putting in new manufacturing lines that are fully automated. According to a company spokesperson in an email to Endpoints News, construction on the site has already started and is expected to begin production in 2024.
Around 80 more jobs are expected to be added once the project is finished, and the company is already actively hiring at the site.
The site primarily makes Acuvue contact lenses for patients with astigmatism and, according to the company, is one of the largest contact lens manufacturing facilities in the world.
“We have been in Limerick for more than 25 years and our success is a testament to our talented workforce,” said John Lynch, the plant leader for J&J Vision Care Ireland, in a statement.
The expansion is not the only J&J project in the works on the Emerald Isle. The company is also expanding its API and monoclonal antibody production facility, also in Limerick, to the tune of $446 million.
Ireland has been awash with building and expansion projects from a wide array of pharma manufacturers.
Last month, both Abbott Laboratories and Horizon announced major projects. Abbott will invest around $451 million to build a new manufacturing plant in Kilkenny to make more of its glucose monitors, while Horizon will build a 320,000-square-foot expansion to the 44,000-square-foot facility they acquired in Waterford last year for $65 million.
This also comes as Merck KGaA, Cambrex, Alexion, AstraZeneca and SK are all embarking on major expansions or building projects in the country this year.